Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

Watchlist Manager
Reviva Pharmaceuticals Holdings, Inc. Logo
Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Watchlist
Price: 1.78 USD 8.54%
Market Cap: 59.5m USD
Have any thoughts about
Reviva Pharmaceuticals Holdings, Inc.?
Write Note

Reviva Pharmaceuticals Holdings, Inc.
Investor Relations

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. The company is headquartered in Cupertino, California and currently employs 5 full-time employees. The company went IPO on 2018-10-18. The firm discovers, develops and seeks to commercialize therapeutics for various diseases. Its pipeline focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics driven technology platform and chemistry to develop new medicines. Its pipeline has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Its primary focus is developing its lead product candidate, RP5063, for the treatment of schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), behavioral and psychotic symptoms, dementia or Alzheimer's disease (BPSD), Parkinson's disease psychosis (PDP), and attention deficit hyperactivity disorder (ADHD). RP5063 also focuses on the treatment of pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). The firm's RP1208, is in pre-clinical development, which focuses on the treatment of depression and obesity.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Laxminarayan Bhat Ph.D.
Founder, CEO, President & Director
No Bio Available
Mr. Narayan Prabhu
Chief Financial Officer
No Bio Available

Contacts

Address
CALIFORNIA
Cupertino
19925 Stevens Creek Blvd., Suite 100
Contacts
+14085018881.0